Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0002019886-24-000019
Filing Date
2024-05-21
Accepted
2024-05-21 16:03:35
Documents
1
Effectiveness Date
2024-05-21
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 9395
  Complete submission text file 0002019886-24-000019.txt   10613
Mailing Address 412 GEORGIA AVENUE SUITE 201 CHATTANOOGA TN 37403
Business Address 412 GEORGIA AVENUE SUITE 201 CHATTANOOGA TN 37403 (423) 243-3460
Solas BioVentures Emerging Healthcare Fund, LP (Filer) CIK: 0001940916 (see all company filings)

EIN.: 883266786 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-463813 | Film No.: 24969239